Skip to content

Clinical trials

Completed Immune System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Status: Completed Clear all

218 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20054
20061
20072
20082
20097
201013
201111
20129
201314
201410
20155
201613
201714
201816
20194
202012
202114
20227
202310
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed218

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)23
National Institute of Allergy and Infectious Diseases (NIAID)6
Pfizer6
AO GENERIUM5
Kadmon, a Sanofi Company5
AstraZeneca4
Ellodi Pharmaceuticals, LP3
Johns Hopkins University3
Memgen, LLC3
National Heart, Lung, and Blood Institute (NHLBI)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases218
Autoimmune Diseases48
Communicable Diseases40
Rare Diseases39
Hypersensitivity27
Hypersensitivity, Immediate21
Lupus Erythematosus, Systemic20
Connective Tissue Diseases17
Skin Diseases17
Nervous System Diseases14

Trials

Showing 76 to 100 of 218. Each trial links to its page on Pharma Observatory.

118 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.